Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more
Basel Medical Group Ltd Ordinary Shares (BMGL) - Total Assets
Latest total assets as of September 2025: $16.85 Million USD
Based on the latest financial reports, Basel Medical Group Ltd Ordinary Shares (BMGL) holds total assets worth $16.85 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Basel Medical Group Ltd Ordinary Shares - Total Assets Trend (2022–2025)
This chart illustrates how Basel Medical Group Ltd Ordinary Shares’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Basel Medical Group Ltd Ordinary Shares - Asset Composition Analysis
Current Asset Composition (June 2025)
Basel Medical Group Ltd Ordinary Shares's total assets of $16.85 Million consist of 77.8% current assets and 22.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.7% |
| Accounts Receivable | $2.49 Million | 14.8% |
| Inventory | $376.29K | 2.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2022–2025)
This chart illustrates how Basel Medical Group Ltd Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Basel Medical Group Ltd Ordinary Shares's current assets represent 77.8% of total assets in 2025, a decrease from 93.0% in 2022.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, up from 9.3% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is accounts receivable at 14.8% of total assets.
Basel Medical Group Ltd Ordinary Shares Competitors by Total Assets
Key competitors of Basel Medical Group Ltd Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
Basel Medical Group Ltd Ordinary Shares - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Basel Medical Group Ltd Ordinary Shares generates 0.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Basel Medical Group Ltd Ordinary Shares is currently not profitable relative to its asset base.
Basel Medical Group Ltd Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.23 | 2.22 | 2.28 |
| Quick Ratio | 1.19 | 2.20 | 2.27 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.43 Million | $ 8.97 Million | $ 8.31 Million |
Basel Medical Group Ltd Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Basel Medical Group Ltd Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.07 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 3.3% |
| Total Assets | $16.85 Million |
| Market Capitalization | $3.63 Million USD |
Valuation Analysis
Below Book Valuation: The market values Basel Medical Group Ltd Ordinary Shares's assets below their book value (0.22 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Basel Medical Group Ltd Ordinary Shares's assets grew by 3.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below shows the annual total assets of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $16.85 Million | +3.35% |
| 2024-06-30 | $16.31 Million | +6.03% |
| 2023-06-30 | $15.38 Million | -8.71% |
| 2022-06-30 | $16.85 Million | -- |